{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:02:33Z","timestamp":1793091753441,"version":"4.5.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The National Lung Screening Trial (NLST) found that screening for lung cancer with low-dose computed tomography (CT) reduced lung cancer\u2013specific and all-cause mortality compared with chest radiography. It is uncertain whether these results apply to a nationally representative target population.<\/jats:p><\/jats:sec>Objective<\/jats:title>To extend inferences about the effects of lung cancer screening strategies from the NLST to a nationally representative target population of NLST-eligible US adults.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This comparative effectiveness study included NLST data from US adults at 33 participating centers enrolled between August 2002 and April 2004 with follow-up through 2009 along with National Health Interview Survey (NHIS) cross-sectional household interview survey data from 2010. Eligible participants were adults aged 55 to 74 years, and were current or former smokers with at least 30 pack-years of smoking (former smokers were required to have quit within the last 15 years). Transportability analyses combined baseline covariate, treatment, and outcome data from the NLST with covariate data from the NHIS and reweighted the trial data to the target population. Data were analyzed from March 2020 to May 2023.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Low-dose CT or chest radiography screening with a screening assessment at baseline, then yearly for 2 more years.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>For the outcomes of lung-cancer specific and all-cause death, mortality rates, rate differences, and ratios were calculated at a median (25th percentile and 75th percentile) follow-up of 5.5 (5.2-5.9) years for lung cancer\u2013specific mortality and 6.5 (6.1-6.9) years for all-cause mortality.<\/jats:p><\/jats:sec>Results<\/jats:title>The transportability analysis included 51\u202f274 NLST participants and 685 NHIS participants representing the target population (of approximately 5\u202f700\u202f000 individuals after survey-weighting). Compared with the target population, NLST participants were younger (median [25th percentile and 75th percentile] age, 60 [57 to 65] years vs 63 [58 to 67] years), had fewer comorbidities (eg, heart disease, 6551 of 51\u202f274 [12.8%] vs 1\u202f025\u202f951 of 5\u202f739\u202f532 [17.9%]), and were more educated (bachelor\u2019s degree or higher, 16\u202f349 of 51\u202f274 [31.9%] vs 859\u202f812 of 5\u202f739\u202f532 [15.0%]). In the target population, for lung cancer\u2013specific mortality, the estimated relative rate reduction was 18% (95% CI, 1% to 33%) and the estimated absolute rate reduction with low-dose CT vs chest radiography was 71 deaths per 100\u202f000 person-years (95% CI, 4 to 138 deaths per 100\u202f000 person-years); for all-cause mortality the estimated relative rate reduction was 6% (95% CI, \u22122% to 12%). In the NLST, for lung cancer\u2013specific mortality, the estimated relative rate reduction was 21% (95% CI, 9% to 32%) and the estimated absolute rate reduction was 67 deaths per 100\u202f000 person-years (95% CI, 27 to 106 deaths per 100\u202f000 person-years); for all-cause mortality, the estimated relative rate reduction was 7% (95% CI, 0% to 12%).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>Estimates of the comparative effectiveness of low-dose CT screening compared with chest radiography in a nationally representative target population were similar to those from unweighted NLST analyses, particularly on the relative scale. Increased uncertainty around effect estimates for the target population reflects large differences in the observed characteristics of trial participants and the target population.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.46295","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T16:45:30Z","timestamp":1706633130000},"page":"e2346295","source":"Crossref","is-referenced-by-count":15,"title":["Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial"],"prefix":"10.1001","volume":"7","author":[{"given":"Sarah E.","family":"Robertson","sequence":"first","affiliation":[{"name":"CAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina R.","family":"Joyce","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon A.","family":"Steingrimsson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stuart","sequence":"additional","affiliation":[{"name":"Departments of Mental Health, Biostatistics, and Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise R.","family":"Aberle","sequence":"additional","affiliation":[{"name":"Medical & Imaging Informatics Group, Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Gatsonis","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa J.","family":"Dahabreh","sequence":"additional","affiliation":[{"name":"CAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"issue":"1","key":"zoi231351r3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1148\/radiol.10091808","article-title":"The National Lung Screening Trial: overview and study design.","volume":"258","author":"Aberle","year":"2011","journal-title":"Radiology"},{"issue":"21","key":"zoi231351r4","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1209120","article-title":"Results of initial low-dose computed tomographic screening for lung cancer.","volume":"368","author":"Church","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi231351r5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi231351r6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US Preventive Services Task Force recommendation statement.","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"zoi231351r7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jama.2021.0377","article-title":"Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"325","author":"Jonas","year":"2021","journal-title":"JAMA"},{"issue":"23","key":"zoi231351r8","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1200\/JCO.20.02574","article-title":"Benefits and harms of lung cancer screening by chest computed tomography: a systematic review and meta-analysis.","volume":"39","author":"Passiglia","year":"2021","journal-title":"J Clin Oncol"},{"issue":"23","key":"zoi231351r9","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/jnci\/djq434","article-title":"Baseline characteristics of participants in the randomized national lung screening trial.","volume":"102","author":"Aberle","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"zoi231351r10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.7326\/M14-1484","article-title":"National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.","volume":"161","author":"Pinsky","year":"2014","journal-title":"Ann Intern Med"},{"issue":"24","key":"zoi231351r11","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1002\/cncr.v121.24","article-title":"Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.","volume":"121","author":"Howard","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"zoi231351r12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10654-019-00533-2","article-title":"Extending inferences from a randomized trial to a target population.","volume":"34","author":"Dahabreh","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"zoi231351r13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/EDE.0000000000001097","article-title":"On the relation between G-formula and inverse probability weighting estimators for generalizing trial results.","volume":"30","author":"Dahabreh","year":"2019","journal-title":"Epidemiology"},{"issue":"5","key":"zoi231351r15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"24","key":"zoi231351r18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/jnci\/94.24.1837","article-title":"Cancer screening practices from National Health Interview Surveys: past, present, and future.","volume":"94","author":"Hiatt","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi231351r19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1158\/1055-9965.EPI-12-0343","article-title":"Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.","volume":"21","author":"Doria-Rose","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"zoi231351r20","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jamaoncol.2016.6416","article-title":"Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015.","volume":"3","author":"Jemal","year":"2017","journal-title":"JAMA Oncol"},{"issue":"14","key":"zoi231351r21","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/sim.v39.14","article-title":"Extending inferences from a randomized trial to a new target population.","volume":"39","author":"Dahabreh","year":"2020","journal-title":"Stat Med"},{"issue":"8","key":"zoi231351r22","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/aje\/kwaa270","article-title":"Study designs for extending causal inferences from a randomized trial to a target population.","volume":"190","author":"Dahabreh","year":"2021","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi231351r23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M17-2701","article-title":"Implications of nine risk prediction models for selecting ever-smokers for computed tomography lung cancer screening.","volume":"169","author":"Katki","year":"2018","journal-title":"Ann Intern Med"},{"issue":"9","key":"zoi231351r24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.7326\/M19-1263","article-title":"Life-gained-based versus risk-based selection of smokers for lung cancer screening.","volume":"171","author":"Cheung","year":"2019","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi231351r25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/JCO.2016.69.2467","article-title":"Lung cancer risk prediction model incorporating lung function: development and validation in the UK Biobank prospective cohort study.","volume":"35","author":"Muller","year":"2017","journal-title":"J Clin Oncol"},{"issue":"21","key":"zoi231351r26","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1001\/jama.2016.6255","article-title":"Development and validation of risk models to select ever-smokers for CT lung cancer screening.","volume":"315","author":"Katki","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"zoi231351r28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward.","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"issue":"25","key":"zoi231351r29","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.v28:25","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"5","key":"zoi231351r30","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/sim.v40.5","article-title":"Generalizing randomized trial findings to a target population using complex survey population data.","volume":"40","author":"Ackerman","year":"2021","journal-title":"Stat Med"},{"issue":"12","key":"zoi231351r31","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1158\/1055-9965.EPI-21-0585","article-title":"Generalizability and transportability of the National Lung Screening Trial data: extending trial results to different populations.","volume":"30","author":"Inoue","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"zoi231351r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19629","article-title":"Association of inclusion of more Black individuals in lung cancer screening with reduced mortality.","volume":"4","author":"Prosper","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi231351r33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models.","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"4","key":"zoi231351r35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jech.2002.006361","article-title":"A definition of causal effect for epidemiological research.","volume":"58","author":"Hern\u00e1n","year":"2004","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"zoi231351r36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/0962280211403597","article-title":"On weighting approaches for missing data.","volume":"22","author":"Li","year":"2013","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"zoi231351r38","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v095.i01","article-title":"Various versatile variances: an object-oriented implementation of clustered covariances in R.","volume":"95","author":"Zeileis","year":"2020","journal-title":"J Stat Soft"},{"issue":"3","key":"zoi231351r39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/EDE.0000000000001177","article-title":"Toward causally interpretable meta-analysis: transporting inferences from multiple randomized trials to a new target population.","volume":"31","author":"Dahabreh","year":"2020","journal-title":"Epidemiology"},{"issue":"6","key":"zoi231351r40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial.","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"key":"zoi231351r41","article-title":"Generalizing and transporting inferences about the effects of treatment assignment subject to nonadherence.","author":"Dahabreh","journal-title":"arXiv"},{"issue":"11","key":"zoi231351r42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25102","article-title":"Patient adherence to screening for lung cancer in the US: a systematic review and meta-analysis.","volume":"3","author":"Lopez-Olivo","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi231351r43","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.7326\/M22-1325","article-title":"Characteristics of persons screened for lung cancer in the United States: a cohort study.","volume":"175","author":"Silvestri","year":"2022","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi231351r44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-019-0447-x","article-title":"End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography.","volume":"25","author":"Ardila","year":"2019","journal-title":"Nat Med"},{"key":"zoi231351r34","first-page":"e18174","article-title":"Weight Trimming and propensity score weighting.","volume-title":"PLoS ONE","author":"Lee","year":"2011"},{"key":"zoi231351r37","first-page":"1","volume-title":"Statistical Models in Epidemiology, the Environment, and Clinical Trials","author":"Robins"},{"key":"zoi231351r1","unstructured":"Epidemiology National Cancer Institute. Surveillance and End Results Program. Cancer stat facts: Lung and bronchus cancer. Accessed September 27, 2021. https:\/\/seer.cancer.gov\/statfacts\/html\/lungb.html"},{"key":"zoi231351r2","unstructured":"American Cancer Society. The American Cancer Society\u2019s facts & figures. Accessed February 7, 2023. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2022.html"},{"key":"zoi231351r14","unstructured":"Ruggles? S, Flood? S, Goeken? R, Schouweiler? M, Sobek? M. IPUMS USA health surveys: National Health Interview Survey, version 12.0. Published online 2022. Accessed February 7, 2023. https:\/\/nhis.ipums.org\/nhis\/"},{"key":"zoi231351r16","unstructured":"National Cancer Institute Cancer Data Access System. National Lung Screening Trial (NLST) datasets. Accessed August 26, 2022. https:\/\/cdas.cancer.gov\/datasets\/nlst\/"},{"key":"zoi231351r17","unstructured":"National Cancer Institute Division of Cancer Control & Population Sciences. National Health Interview Survey (NHIS) cancer control supplement (CCS). Accessed October 12, 2022. https:\/\/healthcaredelivery.cancer.gov\/nhis"},{"key":"zoi231351r27","unstructured":"Yang? D, Dalton? JE. A unified approach to measuring the effect size between two groups using SAS. Semantic Scholar repository. Published online 2012. Accessed February 7, 2023. https:\/\/www.semanticscholar.org\/paper\/A-unified-approach-to-measuring-the-effect-size-two-Yang-Dalton\/6cf4bd36ca4c90006a5d6563f646a391c255581b"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2814338\/robertson_2024_oi_231351_1705911891.87694.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T16:45:38Z","timestamp":1706633138000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2814338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.46295","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]}}}